• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

超级崩解剂对含瑞舒伐他汀的液固分散体片剂的性质及溶出曲线的影响

The effect of superdisintegrants on the properties and dissolution profiles of liquisolid tablets containing rosuvastatin.

作者信息

Vraníková Barbora, Gajdziok Jan, Doležel Petr

机构信息

a Department of Pharmaceutics, Faculty of Pharmacy , University of Veterinary and Pharmaceutical Sciences , Palackeho Trida 1/3 , Brno , Czech Republic.

出版信息

Pharm Dev Technol. 2017 Mar;22(2):138-147. doi: 10.3109/10837450.2015.1089900. Epub 2015 Sep 24.

DOI:10.3109/10837450.2015.1089900
PMID:26401959
Abstract

CONTEXT

The preparation of liquisolid systems (LSS) represents a promising method for enhancing a dissolution rate and bioavailability of poorly soluble drugs. The release of the drug from LSS tablets is affected by many factors, including the disintegration time.

OBJECTIVE

The evaluation of differences among LSS containing varying amounts and types of commercially used superdisintegrants (Kollidon® CL-F, Vivasol® and Explotab®).

MATERIALS AND METHODS

LSS were prepared by spraying rosuvastatin solution onto Neusilin® US2 and further processing into tablets. Varying amounts of superdisintegrants were used and the differences among LSS were evaluated. The multiple scatter plot method was used to visualize the relationships within the obtained data.

RESULTS AND DISCUSSION

All disintegrants do not showed negative effect on the flow properties of powder blends. The type and concentration of superdisintegrant had an impact on the disintegration time and dissolution profiles of tablets. Tablets with Explotab® showed the longest disintegration time and the smallest amount of released drug. Fastest disintegration and dissolution rate were observed in tablets containing Kollidon® CL-F (≥2.5% w/w). Also tablets with Vivasol® (2.5-4.0% w/w) showed fast disintegration and complete drug release.

CONCLUSION

Kollidon® CL-F and Vivasol® in concentration ≥2.5% are suitable superdisintegrants for LSS with enhanced release of drug.

摘要

背景

液固系统(LSS)的制备是提高难溶性药物溶出速率和生物利用度的一种有前景的方法。药物从LSS片剂中的释放受多种因素影响,包括崩解时间。

目的

评估含有不同用量和类型市售超级崩解剂(交联聚维酮CL-F、维法索尔和羧甲基淀粉钠)的LSS之间的差异。

材料与方法

通过将瑞舒伐他汀溶液喷雾到二号硅酸镁铝上制备LSS,并进一步加工成片剂。使用了不同用量的超级崩解剂,并评估了LSS之间的差异。采用多元散射图方法直观呈现所得数据之间的关系。

结果与讨论

所有崩解剂对粉末混合物的流动性均未显示负面影响。超级崩解剂的类型和浓度对片剂的崩解时间和溶出曲线有影响。含有羧甲基淀粉钠的片剂崩解时间最长,药物释放量最小。在含有交联聚维酮CL-F(≥2.5% w/w)的片剂中观察到最快的崩解和溶出速率。含有维法索尔(2.5 - 4.0% w/w) 的片剂也显示出快速崩解和药物完全释放。

结论

浓度≥2.5%的交联聚维酮CL-F和维法索尔是适用于药物释放增强的LSS的超级崩解剂。

相似文献

1
The effect of superdisintegrants on the properties and dissolution profiles of liquisolid tablets containing rosuvastatin.超级崩解剂对含瑞舒伐他汀的液固分散体片剂的性质及溶出曲线的影响
Pharm Dev Technol. 2017 Mar;22(2):138-147. doi: 10.3109/10837450.2015.1089900. Epub 2015 Sep 24.
2
Modern evaluation of liquisolid systems with varying amounts of liquid phase prepared using two different methods.使用两种不同方法制备的具有不同液相含量的液固系统的现代评估。
Biomed Res Int. 2015;2015:608435. doi: 10.1155/2015/608435. Epub 2015 May 17.
3
Experimental Design for Determination of Effects of Superdisintegrant Combinations on Liquisolid System Properties.用于测定超级崩解剂组合对液固系统性质影响的实验设计
J Pharm Sci. 2017 Mar;106(3):817-825. doi: 10.1016/j.xphs.2016.11.002. Epub 2016 Dec 5.
4
Conversion of solid dispersion prepared by acid-base interaction into free-flowing and tabletable powder by using Neusilin® US2.通过使用 Neusilin® US2 将酸碱相互作用制备的固体分散体转化为自由流动和可压片的粉末。
Int J Pharm. 2015 Apr 30;484(1-2):172-80. doi: 10.1016/j.ijpharm.2015.02.060. Epub 2015 Feb 24.
5
Self-microemulsifying tablets prepared by direct compression for improved resveratrol delivery.直接压片法制备的自微乳片剂提高了白藜芦醇的递送效果。
Int J Pharm. 2018 Sep 5;548(1):263-275. doi: 10.1016/j.ijpharm.2018.06.065. Epub 2018 Jun 30.
6
Development of Itraconazole Liquisolid Compact: Effect of Polyvinylpyrrolidone on the Dissolution Properties.伊曲康唑液固复合制剂的研制:聚乙烯吡咯烷酮对溶出特性的影响
Curr Drug Deliv. 2016;13(3):452-61. doi: 10.2174/1567201813666160216144323.
7
Evaluation of different fast melting disintegrants by means of a central composite design.通过中心复合设计评估不同的速熔崩解剂。
Drug Dev Ind Pharm. 2005 Jan;31(1):109-21. doi: 10.1081/ddc-44233.
8
[The Use of Synthetic Polymers (Superdisintegrants) in Technology Tablets Containing Ethanol Dry Extract from Asparagus officinalis].[合成聚合物(超级崩解剂)在含芦笋乙醇提取物的技术片剂中的应用]
Polim Med. 2015 Jul-Dec;45(2):73-80. doi: 10.17219/pim/61167.
9
Development of solid SEDDS, VI: Effect of precoating of Neusilin US2 with PVP on drug release from adsorbed self-emulsifying lipid-based formulations.固体 SEDDS 的研制,VI:将 Neusilin US2 预先包衣聚维酮对吸附自乳化脂质体制剂中药物释放的影响。
Eur J Pharm Sci. 2017 Dec 15;110:124-133. doi: 10.1016/j.ejps.2017.02.022. Epub 2017 Feb 14.
10
DISSOLUTION PROPERTIES AND KINETIC STUDY OF SULFADIMIDINE AND TRIMETHOPRIM TABLETS CONTAINING FOUR DIFFERENT SUPERDISINTEGRANTS.含四种不同超级崩解剂的磺胺二甲嘧啶和甲氧苄啶片剂的溶出特性及动力学研究
Acta Pol Pharm. 2015 Mar-Apr;72(2):347-55.

引用本文的文献

1
Revolutionizing fast disintegrating tablets: Harnessing a dual approach with porous starch and sublimation technique.革新速崩片:采用多孔淀粉与升华技术的双重方法。
Heliyon. 2024 Oct 2;10(19):e38793. doi: 10.1016/j.heliyon.2024.e38793. eCollection 2024 Oct 15.
2
Exploration of Neusilin US2 as an Acceptable Filler in HPMC Matrix Systems-Comparison of Pharmacopoeial and Dynamic Biorelevant Dissolution Study.探索纽西兰US2作为羟丙基甲基纤维素(HPMC)基质系统中可接受填充剂的研究——药典法与动态生物相关溶出度研究的比较
Pharmaceutics. 2022 Jan 5;14(1):127. doi: 10.3390/pharmaceutics14010127.
3
Tripling the Bioavailability of Rosuvastatin Calcium Through Development and Optimization of an In-Situ Forming Nanovesicular System.
通过开发和优化原位形成纳米囊泡系统使瑞舒伐他汀钙的生物利用度提高两倍。
Pharmaceutics. 2019 Jun 11;11(6):275. doi: 10.3390/pharmaceutics11060275.
4
Optimization of the Factors Affecting the Absorption of Vardenafil from Oral Disintegrating Tablets: A Clinical Pharmacokinetic Investigation.伐地那非口腔崩解片吸收影响因素的优化:一项临床药代动力学研究。
Pharmaceutics. 2019 Jan 1;11(1):11. doi: 10.3390/pharmaceutics11010011.
5
A new design for a chronological release profile of etodolac from coated bilayer tablets: and assessment.依托度酸包衣双层片按时间顺序释放曲线的新设计及评估
J Adv Res. 2018 Aug 31;15:37-47. doi: 10.1016/j.jare.2018.08.003. eCollection 2019 Jan.